Cannabinoids are a group of terpenophenolic compounds present in Cannabis (''Cannabis sativa'') and occur naturally in the nervous and immune systems of animals.
A research team from the Department of Neuroscience at the Faculty of Health and Medical Sciences has now made a recent finding that may prove crucial to upcoming studies and treatments using medical cannabis.
When two naturally occurring lipids are altered using a process called epoxidation, they are transformed into powerful agents that target numerous cannabinoid receptors in neurons, disrupting pathways that promote inflammation and pain.
Cannabinoid-containing products may alter the effects of some prescription drugs, according to Penn State College of Medicine researchers.
Constant exposure to cannabis could have an adverse effect on sociability. According to studies, in certain indviduals, such exposures may result in reduced social interactions and withdrawal symptoms.
Researcher Staci Gruber, Ph.D., will use funding provided by Harvard University to further her studies into different types of cannabis-based products.
In an international study published recently, researchers from the University of Saskatchewan report that combined scientific effort would be needed to assemble and map the genome of cannabis to unravel its full potential for human health and agriculture.
Researchers have shown that a solid-state NMR technique can rapidly detect the presence of forensically relevant synthetic cannabinoids.
Researchers in Italy have developed an innovative new platform that can detect residual cannabinoid content in commercially available hemp flours.